Zevra Therapeutics Files 8-K Report
Ticker: ZVRA · Form: 8-K · Filed: Aug 9, 2024 · CIK: 1434647
| Field | Detail |
|---|---|
| Company | Zevra Therapeutics, Inc. (ZVRA) |
| Form Type | 8-K |
| Filed Date | Aug 9, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $6.50, $56.1 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K, financials
Related Tickers: ZEVRA
TL;DR
Zevra Therapeutics (ZEVRA) filed an 8-K on Aug 8th, updating corporate events and financials.
AI Summary
On August 8, 2024, Zevra Therapeutics, Inc. filed an 8-K report detailing other events and financial statements. The company, formerly known as KemPharm, Inc., is incorporated in Delaware and has its principal executive offices in Celebration, Florida.
Why It Matters
This filing provides an update on Zevra Therapeutics' corporate activities and financial reporting, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K report, which typically contains standard corporate information and does not indicate any immediate material changes or risks.
Key Numbers
- 001-36913 — SEC File Number (Identifies the company's filing with the SEC)
- 20-5894398 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- ZEVRA THERAPEUTICS, INC. (company) — Registrant
- KEMPHARM, INC (company) — Former company name
- August 8, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Celebration, FL (location) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of August 8, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on August 8, 2024.
What was Zevra Therapeutics, Inc. formerly known as?
Zevra Therapeutics, Inc. was formerly known as KEMPHARM, INC.
In which state is Zevra Therapeutics, Inc. incorporated?
Zevra Therapeutics, Inc. is incorporated in Delaware.
What is the address of Zevra Therapeutics' principal executive offices?
The address of Zevra Therapeutics' principal executive offices is 1180 Celebration Boulevard, Suite 103, Celebration, FL 34747.
Filing Stats: 904 words · 4 min read · ~3 pages · Grade level 11.2 · Accepted 2024-08-09 17:06:30
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share ZVRA The Nasdaq
- $6.50 — Stock"), at a public offering price of $6.50 per share, pursuant to an effective she
- $56.1 m — from the offering will be approximately $56.1 million, after deducting underwriting dis
Filing Documents
- d723355d8k.htm (8-K) — 28KB
- d723355dex11.htm (EX-1.1) — 230KB
- d723355dex51.htm (EX-5.1) — 12KB
- g723355g0809104457943.jpg (GRAPHIC) — 2KB
- g723355g0809104458147.jpg (GRAPHIC) — 2KB
- 0001193125-24-197943.txt ( ) — 463KB
- zvra-20240808.xsd (EX-101.SCH) — 3KB
- zvra-20240808_lab.xml (EX-101.LAB) — 18KB
- zvra-20240808_pre.xml (EX-101.PRE) — 11KB
- d723355d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Zevra Therapeutics, Inc. Date: August 9, 2024 By: /s/ Timothy J. Sangiovanni Timothy J. Sangiovanni, CPA Senior Vice President, Corporate Controller